A Commonwealth Court judge ruled to allow Pennsylvania medical marijuana companies to resume selling vapes, taken off the market upon request of the Department Of Health last February.
In his 27-page opinion, Commonwealth Court Judge Michael J. Wojcik wrote that state regulators “failed to present any evidence to the court of potential harm to medical marijuana patients due to the recalled products, or more specifically due to the addition of terpenes to these products." Terpenes are natural chemicals taken from other plants and fruits that are used to restore flavors and aromas that the concentrate extraction process destroys.
Some of the lawyers for the cannabis companies that sued state regulators said they were thrilled about the decision.
Medical Marijuana Access And Patient Safety Group
After the PA Department of Health mandated the massive recall and ban of 670 types of cannabis concentrate for vaping — 330,000 units - some of the companies involved formed a group called Medical Marijuana Access & Patient Safety Inc. (MMAPS) to fight the recall in court, claiming it was unfounded.
Curaleaf Holdings Inc. CURLF, Jushi Holdings Inc. JUSH, and Trulieve Cannabis Corp.TCNNF, who were part of the group, said they were facing more than $17 million in collective losses from the recall. Also, they said that some of their products have since expired.
Jim Cacioppo, CEO of Florida-based Jushi Holdings, a leading MMJ operator in PA, said in the statement that the order should “deliver the peace of mind" that these MMJ products did not present the health risks the Health Dept. had alleged.
“In fact, the court noted the Department itself (previously) approved the recalled products for patient use following stringent quality and safety testing and found no evidence of a single adverse event related to any recalled product,” Cacioppo said.
Lead counsel for the group, Judith Cassel, encouraged the PA Dept of Health to “discuss expeditiously resolving this matter in advance of a protracted litigation process.”
The Health Department did not respond but rather announced that it will appeal the decision to the Pennsylvania Supreme Court.
So, stay tuned, it's not over yet.
Photo By Sasun Bughdaryan On Unsplash
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.